List Biotherapeutics
Latest round
- Series A
Last raised
- Dec 2021
Total raised
- $31M
Investors
- 5
About List Biotherapeutics
Founded in 2021 and based in Indiana, US, List Biotherapeutics Inc is a CDMO with expertise in early-stage clinical trial development and cGMP manufacturing., as well as a sister company to List Labs (List Biological Laboratories). Jonathan Yongwan Jo is the president and CEO of the company. The company offers CMO services for late-stage clinical trials and commercialization of Live Biotherapeutics derived from beneficial bacteria.
Who invested in List Biotherapeutics
5 investors across 1 round
See all investors in List Biotherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 1, 2021
Amount
$31M
Investors
Questions about List Biotherapeutics
Who invested in List Biotherapeutics?
List Biotherapeutics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has List Biotherapeutics raised?
List Biotherapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did List Biotherapeutics last raise money?
List Biotherapeutics's most recent round on record is a Series A, in Dec 2021.
What does List Biotherapeutics do?
Founded in 2021 and based in Indiana, US, List Biotherapeutics Inc is a CDMO with expertise in early-stage clinical trial development and cGMP manufacturing.
Where is List Biotherapeutics headquartered?
List Biotherapeutics is headquartered in US.
Which VCs invest in companies like List Biotherapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at List Biotherapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like List Biotherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.